Evidence map›Paper›PMID 40259037›Full record

ArticleScientific reports2025

Prediction of tablet disintegration time based on formulations properties via artificial intelligence by comparing machine learning models and validation.

Mohammed Ghazwani, Umme Hani

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed GhazwaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, Abha, 62223, Saudi Arabia. myghazwani@kku.edu.sa.
Umme HaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, Abha, 62223, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research assesses multiple predictive models aimed at estimating disintegration time for pharmaceutical oral formulations, based on a dataset comprising nearly 2,000 data points that include molecular, physical, compositional, and formulation attributes. Drug and formulation properties were considered as the inputs to estimate the output which is tablet disintegration time. Advanced machine learning methods, including Bayesian Ridge Regression (BRR), Relevance Vector Machine (RVM), and Sparse Bayesian Learning (SBL) were utilized after comprehensive preprocessing involving outlier detection, normalization, and feature selection. Grey Wolf Optimization (GWO) was utilized for model optimization to obtain optimal combinations of hyper-parameters. Among the models, SBL stood out for its superior performance, achieving the highest R² scores and the lowest Root Mean Square Error (RMSE) and Mean Absolute Percentage Error (MAPE) error rates in both the training and testing phases. It also demonstrated robustness and effectively avoided overfitting. SHapley Additive exPlanations (SHAP) analysis provided valuable insights into feature contributions, highlighting wetting time and sodium saccharin as key factors influencing disintegration time.

Indexed as

Artificial IntelligenceMachine LearningTabletsBayes TheoremChemistry, PharmaceuticalTabletsDisintegration timeDrug releaseMachine learningPharmaceutical formulation

Identifiers

PMID40259037
PMCPMC12012149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.